Conagen: Conagen's fermentation platform develops new vitamin K2 forms, targets heart health

02 Nov 2022 --- Conagen is introducing its fermentation-derived vitamin K2, a high-purity all-trans menaquinone-7 (MK-7). It is pegged as the first molecule produced by the proprietary fermentation platform, which produces pure, long-chain menaquinone forms of vitamin K2. Supplementation with the latter may improve cardiovascular and bone health.